Operating CF
$1.67B
Capex
$162.10M
Free Cash Flow
$1.84B
FCF Margin
+109.7%
Cash flow waterfall for Zimmer Biomet Holdings (ZBH) — TTM through Q1 2026
Free cash flow: $1.84B
Cash flow breakdown for Zimmer Biomet Holdings (ZBH) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $1.67B | $1.67B |
| Capital Expenditure | $162.10M | $1.84B |
| Free Cash Flow | $1.84B | $1.84B |
| Acquisitions | −$1.39B | $442.30M |
| Other Investing | −$797.60M | −$355.30M |
| Share Buybacks | −$270.30M | −$625.60M |
| Dividends Paid | −$189.40M | −$815.00M |
| Net Debt Change | $138.60M | −$676.40M |
| Other Financing & FX | −$284.10M | −$960.50M |
| Net Cash Decrease | −$960.30M | −$960.30M |
- Operating Cash Flow$1.67B
- Capital Expenditure$162.10M
- Free Cash Flow$1.84B
- Acquisitions−$1.39B
- Other Investing−$797.60M
- Share Buybacks−$270.30M
- Dividends Paid−$189.40M
- Net Debt Change$138.60M
- Other Financing & FX−$284.10M
- Net Cash Decrease−$960.30M
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Zimmer Biomet Holdings (ZBH) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement